Reduced cigarette smoking during injectable extended-release naltrexone treatment for opioid use disorder.

Background: The prevalence of tobacco cigarette smoking in the US has declined to approximately 15%, yet, it remains over 90% among individuals with opioid use disorder regardless of whether they a...